Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 274

1.

Managing Addiction: Guidelines for Patients With Cancer.

McNally GA, Sica A, Wiczer T.

Clin J Oncol Nurs. 2019 Dec 1;23(6):655-658. doi: 10.1188/19.CJON.655-658.

PMID:
31730608
2.

Adverse events related to abiraterone and enzalutamide treatment: analysis of the EudraVigilance database and meta-analysis of registrational phase III studies.

De Nunzio C, Lombardo R, Tema G, Voglino O, Sica A, Baldassarri V, Nacchia A, Iacovelli R, Bracarda S, Tubaro A.

Prostate Cancer Prostatic Dis. 2019 Nov 4. doi: 10.1038/s41391-019-0182-x. [Epub ahead of print]

PMID:
31685981
3.

Atypical haemolytic-uraemic syndrome in patient with metastatic colorectal cancer treated with fluorouracil and oxaliplatin: a case report and a review of literature.

Viscardi G, Zanaletti N, Ferrara MG, Sica A, Falcone U, Guastafierro S, Bracale U, Ribero D, Fasano M, Napolitano S, Vitale P, De Falco V, Giunta EF, Martinelli E, Ciardiello D, Ciardiello F, Troiani T.

ESMO Open. 2019 Sep 19;4(5):e000551. doi: 10.1136/esmoopen-2019-000551. eCollection 2019.

4.

Cancer- and Non-cancer Related Chronic Pain: From the Physiopathological Basics to Management.

Sica A, Casale B, Dato MTD, Calogero A, Spada A, Sagnelli C, Santagata M, Buonavolontà P, Fiorelli A, Salzano A, Dodaro CA, Martinelli E, Saracco E, Troiani T, Tammaro D, Ciardiello F, Papa A.

Open Med (Wars). 2019 Oct 17;14:761-766. doi: 10.1515/med-2019-0088. eCollection 2019.

5.

A preliminary study for quantitative assessment with HFUS (High Frequency ultrasound) of nodular skin melanoma Breslow thickness in adults before surgery: Interdisciplinary team experience.

Reginelli A, Belfiore MP, Russo A, Turriziani F, Moscarella E, Troiani T, Brancaccio G, Ronchi A, Giunta E, Sica A, Iovino F, Ciardiello F, Franco R, Argenziano G, Grassi R, Cappabianca S.

Curr Radiopharm. 2019 Oct 7. doi: 10.2174/1874471012666191007121626. [Epub ahead of print]

PMID:
31589132
6.

Myelopoiesis, metabolism and therapy: a crucial crossroads in cancer progression.

Sica A, Guarneri V, Gennari A.

Cell Stress. 2019 Jul 1;3(9):284-294. doi: 10.15698/cst2019.09.197. Review.

7.

Decay-Associated Fourier Spectroscopy: Visible to Shortwave Infrared Time-Resolved Photoluminescence Spectra.

Atallah TL, Sica AV, Shin AJ, Friedman HC, Kahrobai YK, Caram JR.

J Phys Chem A. 2019 Aug 8;123(31):6792-6798. doi: 10.1021/acs.jpca.9b04924. Epub 2019 Jul 26.

PMID:
31288509
8.

SPARC Is a New Myeloid-Derived Suppressor Cell Marker Licensing Suppressive Activities.

Sangaletti S, Talarico G, Chiodoni C, Cappetti B, Botti L, Portararo P, Gulino A, Consonni FM, Sica A, Randon G, Di Nicola M, Tripodo C, Colombo MP.

Front Immunol. 2019 Jun 20;10:1369. doi: 10.3389/fimmu.2019.01369. eCollection 2019.

9.

A Proteomic Analysis of GSD-1a in Mouse Livers: Evidence for Metabolic Reprogramming, Inflammation, and Macrophage Polarization.

Cangelosi D, Resaz R, Petretto A, Segalerba D, Ognibene M, Raggi F, Mastracci L, Grillo F, Bosco MC, Varesio L, Sica A, Colombo I, Eva A.

J Proteome Res. 2019 Jul 5;18(7):2965-2978. doi: 10.1021/acs.jproteome.9b00309. Epub 2019 Jun 20.

PMID:
31173686
10.

Membrane Cholesterol Regulates Macrophage Plasticity in Cancer.

Sica A, Bleve A, Garassino MC.

Cell Metab. 2019 Jun 4;29(6):1238-1240. doi: 10.1016/j.cmet.2019.05.011.

PMID:
31167119
11.

Smoking reduces PSA accuracy for detection of prostate cancer: results from an Italian cross-sectional study.

De Nunzio C, Tema G, Trucchi A, Cicione A, Sica A, Lombardo R, Tubaro A.

Minerva Urol Nefrol. 2019 May 28. doi: 10.23736/S0393-2249.19.03360-5. [Epub ahead of print]

PMID:
31144489
12.

Dermoscopic characterization of folliculotropic mycosis fungoides selectively localized on trunk and limbs.

Caccavale S, Vitiello P, Franco R, Panarese I, Ronchi A, Sica A, Jurakic Toncic R, Alfano R, Argenziano G.

Int J Dermatol. 2019 Oct;58(10):e187-e189. doi: 10.1111/ijd.14490. Epub 2019 May 28. No abstract available.

PMID:
31135956
13.

Myeloid-Derived Suppressor Cells: Ductile Targets in Disease.

Consonni FM, Porta C, Marino A, Pandolfo C, Mola S, Bleve A, Sica A.

Front Immunol. 2019 May 3;10:949. doi: 10.3389/fimmu.2019.00949. eCollection 2019. Review.

14.

Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors.

Fucà G, Galli G, Poggi M, Lo Russo G, Proto C, Imbimbo M, Ferrara R, Zilembo N, Ganzinelli M, Sica A, Torri V, Colombo MP, Vernieri C, Balsari A, de Braud F, Garassino MC, Signorelli D.

ESMO Open. 2019 Feb 27;4(1):e000457. doi: 10.1136/esmoopen-2018-000457. eCollection 2019.

15.

Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): what to add and what to leave out.

Proto C, Ferrara R, Signorelli D, Lo Russo G, Galli G, Imbimbo M, Prelaj A, Zilembo N, Ganzinelli M, Pallavicini LM, De Simone I, Colombo MP, Sica A, Torri V, Garassino MC.

Cancer Treat Rev. 2019 May;75:39-51. doi: 10.1016/j.ctrv.2019.03.004. Epub 2019 Mar 28. Review.

16.

Nicotinamide Phosphoribosyltransferase Acts as a Metabolic Gate for Mobilization of Myeloid-Derived Suppressor Cells.

Travelli C, Consonni FM, Sangaletti S, Storto M, Morlacchi S, Grolla AA, Galli U, Tron GC, Portararo P, Rimassa L, Pressiani T, Mazzone M, Trovato R, Ugel S, Bronte V, Tripodo C, Colombo MP, Genazzani AA, Sica A.

Cancer Res. 2019 Apr 15;79(8):1938-1951. doi: 10.1158/0008-5472.CAN-18-1544. Epub 2019 Feb 18.

PMID:
30777853
17.

Intensity of estrus following an estradiol-progesterone-based ovulation synchronization protocol influences fertility outcomes.

Madureira AML, Polsky LB, Burnett TA, Silper BF, Soriano S, Sica AF, Pohler KG, Vasconcelos JLM, Cerri RLA.

J Dairy Sci. 2019 Apr;102(4):3598-3608. doi: 10.3168/jds.2018-15129. Epub 2019 Feb 7.

PMID:
30738666
18.

Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell Lymphomas.

Merli M, Frigeni M, Alric L, Visco C, Besson C, Mannelli L, Di Rocco A, Ferrari A, Farina L, Pirisi M, Piazza F, Loustaud-Ratti V, Arcari A, Marino D, Sica A, Goldaniga M, Rusconi C, Gentile M, Cencini E, Benanti F, Rumi MG, Ferretti VV, Grossi P, Gotti M, Sciarra R, Tisi MC, Cano I, Zuccaro V, Passamonti F, Arcaini L.

Oncologist. 2019 Aug;24(8):e720-e729. doi: 10.1634/theoncologist.2018-0331. Epub 2018 Dec 14.

PMID:
30552159
19.

Targeting Cancer Cells and Tumor Microenvironment in Preclinical and Clinical Models of Hodgkin Lymphoma Using the Dual PI3Kδ/γ Inhibitor RP6530.

Locatelli SL, Careddu G, Serio S, Consonni FM, Maeda A, Viswanadha S, Vakkalanka S, Castagna L, Santoro A, Allavena P, Sica A, Carlo-Stella C.

Clin Cancer Res. 2019 Feb 1;25(3):1098-1112. doi: 10.1158/1078-0432.CCR-18-1133. Epub 2018 Oct 23.

PMID:
30352904
20.

Choosing the Best Chemotherapy Agent to Boost Immune Checkpoint Inhibition Activity.

Garassino MC, Torri V, Colombo MP, Sica A.

Cancer Res. 2018 Oct 15;78(20):5729-5730. doi: 10.1158/0008-5472.CAN-18-2245.

21.

Metabolic influence on the differentiation of suppressive myeloid cells in cancer.

Porta C, Marino A, Consonni FM, Bleve A, Mola S, Storto M, Riboldi E, Sica A.

Carcinogenesis. 2018 Sep 21;39(9):1095-1104. doi: 10.1093/carcin/bgy088. Review.

PMID:
29982315
22.

Protumor Steering of Cancer Inflammation by p50 NF-κB Enhances Colorectal Cancer Progression.

Porta C, Ippolito A, Consonni FM, Carraro L, Celesti G, Correale C, Grizzi F, Pasqualini F, Tartari S, Rinaldi M, Bianchi P, Balzac F, Vetrano S, Turco E, Hirsch E, Laghi L, Sica A.

Cancer Immunol Res. 2018 May;6(5):578-593. doi: 10.1158/2326-6066.CIR-17-0036. Epub 2018 Mar 27.

23.

Radiofrequency ablation of osteoid osteoma.

De Filippo M, Russo U, Papapietro VR, Ceccarelli F, Pogliacomi F, Vaienti E, Piccolo C, Capasso R, Sica A, Cioce F, Carbone M, Bruno F, Masciocchi C, Miele V.

Acta Biomed. 2018 Jan 19;89(1-S):175-185. doi: 10.23750/abm.v89i1-S.7021. Review.

24.

Imaging of pediatric foot disorders.

Reginelli A, Russo A, Turrizziani F, Picascia R, Micheletti E, Galeazzi V, Russo U, Sica A, Cioce F, Aliprandi A, Giovagnoni A, Cappabianca S.

Acta Biomed. 2018 Jan 19;89(1-S):34-47. doi: 10.23750/abm.v89i1-S.7009. Review.

25.

GADD45β Loss Ablates Innate Immunosuppression in Cancer.

Verzella D, Bennett J, Fischietti M, Thotakura AK, Recordati C, Pasqualini F, Capece D, Vecchiotti D, D'Andrea D, Di Francesco B, De Maglie M, Begalli F, Tornatore L, Papa S, Lawrence T, Forbes SJ, Sica A, Alesse E, Zazzeroni F, Franzoso G.

Cancer Res. 2018 Mar 1;78(5):1275-1292. doi: 10.1158/0008-5472.CAN-17-1833. Epub 2017 Dec 26.

26.

Editorial.

Sica A.

Curr Opin Pharmacol. 2017 Aug;35:vii-ix. doi: 10.1016/j.coph.2017.11.002. No abstract available.

PMID:
29241832
27.

Tumor-associated myeloid cells: new understandings on their metabolic regulation and their influence in cancer immunotherapy.

Porta C, Sica A, Riboldi E.

FEBS J. 2018 Feb;285(4):717-733. doi: 10.1111/febs.14288. Epub 2017 Oct 26. Review.

28.

Daily lying behavior of lactating Holstein cows during an estrus synchronization protocol and its associations with fertility.

Silper BF, Madureira AML, Polsky LB, Soriano S, Sica AF, Vasconcelos JLM, Cerri RLA.

J Dairy Sci. 2017 Oct;100(10):8484-8495. doi: 10.3168/jds.2016-12160. Epub 2017 Aug 10.

29.

Association between ambient temperature and humidity, vaginal temperature, and automatic activity monitoring on induced estrus in lactating cows.

Polsky LB, Madureira AML, Filho ELD, Soriano S, Sica AF, Vasconcelos JLM, Cerri RLA.

J Dairy Sci. 2017 Oct;100(10):8590-8601. doi: 10.3168/jds.2017-12656. Epub 2017 Aug 9.

30.

Myeloid suppressor cells in cancer and autoimmunity.

Sica A, Massarotti M.

J Autoimmun. 2017 Dec;85:117-125. doi: 10.1016/j.jaut.2017.07.010. Epub 2017 Jul 17. Review.

PMID:
28728794
31.

Inflammation as target in cancer therapy.

Marelli G, Sica A, Vannucci L, Allavena P.

Curr Opin Pharmacol. 2017 Aug;35:57-65. doi: 10.1016/j.coph.2017.05.007. Epub 2017 Jun 12. Review.

PMID:
28618326
32.

Metabolic regulation of suppressive myeloid cells in cancer.

Sica A, Strauss L, Consonni FM, Travelli C, Genazzani A, Porta C.

Cytokine Growth Factor Rev. 2017 Jun;35:27-35. doi: 10.1016/j.cytogfr.2017.05.002. Epub 2017 May 3. Review.

PMID:
28499577
33.

Tumor-associated myeloid cells as guiding forces of cancer cell stemness.

Sica A, Porta C, Amadori A, Pastò A.

Cancer Immunol Immunother. 2017 Aug;66(8):1025-1036. doi: 10.1007/s00262-017-1997-8. Epub 2017 Apr 11. Review.

PMID:
28401258
34.

Energy metabolism drives myeloid-derived suppressor cell differentiation and functions in pathology.

Sica A, Strauss L.

J Leukoc Biol. 2017 Aug;102(2):325-334. doi: 10.1189/jlb.4MR1116-476R. Epub 2017 Feb 21. Review.

PMID:
28223316
35.

VEGF blockade enhances the antitumor effect of BRAFV600E inhibition.

Comunanza V, Corà D, Orso F, Consonni FM, Middonti E, Di Nicolantonio F, Buzdin A, Sica A, Medico E, Sangiolo D, Taverna D, Bussolino F.

EMBO Mol Med. 2017 Feb;9(2):219-237. doi: 10.15252/emmm.201505774.

36.

Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophages.

Raggi C, Correnti M, Sica A, Andersen JB, Cardinale V, Alvaro D, Chiorino G, Forti E, Glaser S, Alpini G, Destro A, Sozio F, Di Tommaso L, Roncalli M, Banales JM, Coulouarn C, Bujanda L, Torzilli G, Invernizzi P.

J Hepatol. 2017 Jan;66(1):102-115. doi: 10.1016/j.jhep.2016.08.012. Epub 2016 Sep 1.

37.

Learning From Mistakes: Importance of a Multidisciplinary Group, A Case Report.

Pezzulla D, Scoglio C, Capasso R, Cioce F, Sica A, Cappabianca S.

World J Oncol. 2016 Aug;7(4):91-93. doi: 10.14740/wjon968e. Epub 2016 Sep 3.

38.

Gynecomastia: a common indication for mammography in men of all age.

Capasso R, Sica A, D'Amora M, Mostardi M, Martella I, Totaro M, Della Casa G, Vallara M, Pesce A, Gatta G, Cappabianca S.

Acta Biomed. 2016 Jul 28;87 Suppl 3:63-8.

PMID:
27467870
39.

Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards.

Bronte V, Brandau S, Chen SH, Colombo MP, Frey AB, Greten TF, Mandruzzato S, Murray PJ, Ochoa A, Ostrand-Rosenberg S, Rodriguez PC, Sica A, Umansky V, Vonderheide RH, Gabrilovich DI.

Nat Commun. 2016 Jul 6;7:12150. doi: 10.1038/ncomms12150. Review.

40.

CT Appearance of Hepatocellular Carcinoma after Locoregional Treatments: A Comprehensive Review.

Marin D, Cappabianca S, Serra N, Sica A, Lassandro F, D'Angelo R, La Porta M, Fiore F, Somma F.

Gastroenterol Res Pract. 2015;2015:670965. doi: 10.1155/2015/670965. Epub 2015 Dec 22. Review.

41.

Molecular and epigenetic basis of macrophage polarized activation.

Porta C, Riboldi E, Ippolito A, Sica A.

Semin Immunol. 2015 Aug;27(4):237-48. doi: 10.1016/j.smim.2015.10.003. Review.

PMID:
26561250
42.

RORC1 Regulates Tumor-Promoting "Emergency" Granulo-Monocytopoiesis.

Strauss L, Sangaletti S, Consonni FM, Szebeni G, Morlacchi S, Totaro MG, Porta C, Anselmo A, Tartari S, Doni A, Zitelli F, Tripodo C, Colombo MP, Sica A.

Cancer Cell. 2015 Aug 10;28(2):253-69. doi: 10.1016/j.ccell.2015.07.006.

43.

Macrophage polarization in pathology.

Sica A, Erreni M, Allavena P, Porta C.

Cell Mol Life Sci. 2015 Nov;72(21):4111-26. doi: 10.1007/s00018-015-1995-y. Epub 2015 Jul 26. Review.

PMID:
26210152
44.

Cancer stem cells and tumor-associated macrophages: a roadmap for multitargeting strategies.

Raggi C, Mousa HS, Correnti M, Sica A, Invernizzi P.

Oncogene. 2016 Feb 11;35(6):671-82. doi: 10.1038/onc.2015.132. Epub 2015 May 11. Review.

PMID:
25961921
45.

Prevalence and characteristics of true and apparent treatment resistant hypertension in the Campania Salute Network.

Izzo R, Stabile E, Esposito G, Trimarco V, De Marco M, Sica A, Manzi MV, Gargiulo G, Schiattarella G, Rozza F, De Luca N, de Simone G.

Int J Cardiol. 2015 Apr 1;184:417-9. doi: 10.1016/j.ijcard.2015.03.022. Epub 2015 Mar 3. No abstract available.

PMID:
25755055
46.

The effects of superoxide dismutase addition to the transport medium on cumulus-oocyte complex apoptosis and IVF outcome in cats (Felis catus).

Cocchia N, Corteggio A, Altamura G, Tafuri S, Rea S, Rosapane I, Sica A, Landolfi F, Ciani F.

Reprod Biol. 2015 Mar;15(1):56-64. doi: 10.1016/j.repbio.2014.10.002. Epub 2014 Oct 16.

PMID:
25726378
47.

Chronic exposure to TGFβ1 regulates myeloid cell inflammatory response in an IRF7-dependent manner.

Cohen M, Matcovitch O, David E, Barnett-Itzhaki Z, Keren-Shaul H, Blecher-Gonen R, Jaitin DA, Sica A, Amit I, Schwartz M.

EMBO J. 2014 Dec 17;33(24):2906-21. doi: 10.15252/embj.201489293. Epub 2014 Nov 10.

48.

Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples.

Alemany L, Saunier M, Tinoco L, Quirós B, Alvarado-Cabrero I, Alejo M, Joura EA, Maldonado P, Klaustermeier J, Salmerón J, Bergeron C, Petry KU, Guimerà N, Clavero O, Murillo R, Clavel C, Wain V, Geraets DT, Jach R, Cross P, Carrilho C, Molina C, Shin HR, Mandys V, Nowakowski AM, Vidal A, Lombardi L, Kitchener H, Sica AR, Magaña-León C, Pawlita M, Quint W, Bravo IG, Muñoz N, de Sanjosé S, Bosch FX; HPV VVAP study group.

Eur J Cancer. 2014 Nov;50(16):2846-54. doi: 10.1016/j.ejca.2014.07.018. Epub 2014 Aug 21.

PMID:
25155250
49.

Macrophage activation and polarization: nomenclature and experimental guidelines.

Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, Goerdt S, Gordon S, Hamilton JA, Ivashkiv LB, Lawrence T, Locati M, Mantovani A, Martinez FO, Mege JL, Mosser DM, Natoli G, Saeij JP, Schultze JL, Shirey KA, Sica A, Suttles J, Udalova I, van Ginderachter JA, Vogel SN, Wynn TA.

Immunity. 2014 Jul 17;41(1):14-20. doi: 10.1016/j.immuni.2014.06.008.

50.

Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy.

Ries CH, Cannarile MA, Hoves S, Benz J, Wartha K, Runza V, Rey-Giraud F, Pradel LP, Feuerhake F, Klaman I, Jones T, Jucknischke U, Scheiblich S, Kaluza K, Gorr IH, Walz A, Abiraj K, Cassier PA, Sica A, Gomez-Roca C, de Visser KE, Italiano A, Le Tourneau C, Delord JP, Levitsky H, Blay JY, Rüttinger D.

Cancer Cell. 2014 Jun 16;25(6):846-59. doi: 10.1016/j.ccr.2014.05.016. Epub 2014 Jun 2.

Supplemental Content

Support Center